Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alginos plus Nexium for Nighttime Reflux in Erosive GERD
NCT02277886Phase 4Unknown
- Sponsor
- Chang Gung Memorial Hospital
- Start
- Nov 2014
- Primary completion
- Jun 2016
- Modality
- Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of Alginos in gastroesophageal reflux disease (GERD), sponsored by Chang Gung Memorial Hospital. Status: unknown.
02
Drugs
Alginos
03
Conditions
gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT02277886.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02277886.